160 related articles for article (PubMed ID: 33813428)
1. Tumor Size and N2 Lymph Node Metastasis Are Significant Risk Factors for Early Recurrence in Completely Resected Centrally Located Primary Lung Cancer Patients.
Tsukioka T; Izumi N; Komatsu H; Inoue H; Miyamoto H; Ito R; Kimura T; Nishiyama N
Anticancer Res; 2021 Apr; 41(4):2165-2169. PubMed ID: 33813428
[TBL] [Abstract][Full Text] [Related]
2. Combined sleeve lobectomy for centrally located primary lung cancer and lung cancer with hilar lymph node metastasis.
Tsukioka T; Izumi N; Komatsu H; Inoue H; Miyamoto H; Ito R; Kimura T; Nishiyama N
Jpn J Clin Oncol; 2020 Jul; 50(7):794-799. PubMed ID: 32211775
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
[TBL] [Abstract][Full Text] [Related]
4. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?
Asamura H; Nakayama H; Kondo H; Tsuchiya R; Shimosato Y; Naruke T
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1125-34. PubMed ID: 8642812
[TBL] [Abstract][Full Text] [Related]
5. Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.
Tsukioka T; Izumi N; Kyukwang C; Komatsu H; Toda M; Hara K; Nishiyama N
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):121-126. PubMed ID: 29459570
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes of sleeve resections performed for non-small cell lung cancer; A single center experience.
Sayan M; Bas A; Gokce A; Dikmen AU; Celik A; Kurul IC; Tastepe AI
Niger J Clin Pract; 2020 Jun; 23(6):829-834. PubMed ID: 32525119
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
9. Early recurrence of completely resected N2-positive non-small-cell lung cancer.
Tsukioka T; Nishiyama N; Iwata T; Izumi N; Mizuguchi S; Morita R; Inoue K; Suehiro S
Gen Thorac Cardiovasc Surg; 2007 Mar; 55(3):113-8. PubMed ID: 17447509
[TBL] [Abstract][Full Text] [Related]
10. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Kim YT; Kang CH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
[TBL] [Abstract][Full Text] [Related]
11. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
12. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
[TBL] [Abstract][Full Text] [Related]
13. Extended sleeve lobectomy for centrally located non-small-cell lung cancer: a 20-year single-centre experience.
Hong TH; Cho JH; Shin S; Kim HK; Choi YS; Zo JI; Shim YM; Kim J
Eur J Cardiothorac Surg; 2018 Jul; 54(1):142-148. PubMed ID: 29408983
[TBL] [Abstract][Full Text] [Related]
14. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
15. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy.
Okada M; Yamagishi H; Satake S; Matsuoka H; Miyamoto Y; Yoshimura M; Tsubota N
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):814-9. PubMed ID: 10733774
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
18. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
19. Video-Assisted Vs Thoracotomy Sleeve Lobectomy for Lung Cancer: A Propensity Matched Analysis.
Gao HJ; Jiang ZH; Gong L; Ma K; Ren P; Yu ZT; Wei YC
Ann Thorac Surg; 2019 Oct; 108(4):1072-1079. PubMed ID: 31163131
[TBL] [Abstract][Full Text] [Related]
20. Sleeve lobectomy for bronchogenic cancers: factors affecting survival.
Fadel E; Yildizeli B; Chapelier AR; Dicenta I; Mussot S; Dartevelle PG
Ann Thorac Surg; 2002 Sep; 74(3):851-8; discussion 858-9. PubMed ID: 12238850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
